Yahoo Web Search

  1. Ad
    related to MERCK & CO., INC
  1. Moleculin Completes Enrollment in Early-Stage Cancer Study

    Zacks via Yahoo FinanceAug 15 11:55 AM

    Moleculin Biotech, Inc. MBRX announced that it has completed enrollment in the proof-of-concept clinical study evaluating its p-STAT3 inhibitor candidate, WP1220...skin cancer. The company ...

  2. Wall Street's main indexes have had a slow start to the week, retreating on Monday, and participants are bracing for what message the Fed will send if it pushes ahead with a well-telegraphed ...

  3. Apple Inc's results after markets close illuminate the impact of trade tensions with China.

  4. U.S. stock index futures dropped on Tuesday, as worries about the scale of consensus at the Federal Reserve in favor of deeper cuts in interest rates ate into the positive sentiment that drove ...

  5. Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 10 5:43 AM

    Thank you for standing by and welcome to the Agenus Second Quarter 2019 Conference Call. In the first half of 2019, we have continued to deliver new discoveries to the clinic, and advance our ...

  6. PD-L1 inhibitors available on the market are Merck’s MRK Keytruda, AstraZeneca’s AZN Imfinzi, Bristol Myers’ BMY Opdivo, Roche’s Tecentriq and Pfizer’s PFE Bavencio. ...

  7. In a separate press release, AstraZeneca announced that the phase III study (PAOLA-1) evaluating its and Merck's MRK PARP inhibitor, Lynparza, for a broader advanced ovarian cancer patient ...

  8. Johnson & Johnson JNJ announced that the FDA has granted accelerated approval to its antimycobacterial tablets, Sirturo (bedaquiline) as a combination therapy to treat adolescents with pulmonary ...

  9. Future dividend growth will depend on earnings growth as well as payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. The Zacks Consensus ...

  10. Edited Transcript of CDXS earnings conference call or presentation 6-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceAug 09 17:32 PM

    Nicols, Codexis, Inc. - President, CEO & Director [3] -------------------------------------------------------------------------------- Thanks...sales. Product sales were up 68% year-over-year ...

  1. Ads
    related to MERCK & CO., INC